---
title: "Weekly Recap | Hinge Health +5.75%, most brokers rate it buy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298098349.md"
description: "Hinge Health (HNGE) rose 5.75% this week to close at $92.37, while the S&P 500 edged up just 0.09%, leaving the stock about 5.66 percentage points ahead of the benchmark. Monday (Aug 31) gapped higher, dipped to an intraday low of $85.75, and then recovered to close at $92.56, setting the tone for the week. Tuesday and Thursday saw pullbacks, but Friday (Sep 4) brought the shares back to $92.37. The weekly range was $85.75 to $93."
datetime: "2026-09-05T07:02:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298098349.md)
  - [en](https://longbridge.com/en/news/298098349.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298098349.md)
generator: "portal-rs"
---

# Weekly Recap | Hinge Health +5.75%, most brokers rate it buy

## The Week

Hinge Health (HNGE) rose 5.75% this week to close at $92.37, while the S&P 500 edged up just 0.09%, leaving the stock about 5.66 percentage points ahead of the benchmark. Monday (Aug 31) gapped higher, dipped to an intraday low of $85.75, and then recovered to close at $92.56, setting the tone for the week. Tuesday and Thursday saw pullbacks, but Friday (Sep 4) brought the shares back to $92.37. The weekly range was $85.75 to $93.30, making it a rally followed by narrow consolidation rather than a steady climb.

## Key Events

The most direct company-specific item was a Form 144 filing on Sep 4, disclosing director Elliott Robinson’s planned disposal of $6.74m worth of common shares. Because Form 144 involves insider-related share sales and the amount was modest in the context of the stock’s daily turnover, the market took it calmly. Most of the other news this week was sector-wide, touching on AI computing, shipping and data-centre power themes. Hinge Health was caught up in the broader narrative without any major announcement tied to its own business.

## Analyst Ratings

Among 16 covering brokers, 8 rate the stock a buy, 7 overweight, and 1 hold, with no underweight or sell ratings. The consensus recommendation is buy, and the consensus target of $106.47 sits about 15.26% above the $92.37 close. Targets range from $85.00 to $140.00, a 55-dollar spread that points to meaningful disagreement. The stock ranks 10th among 53 names in the healthcare services industry.

## The Week Ahead

The macro calendar is heavy in the coming days. On Sep 8 (Tue), the NFIB small business optimism index is due. Sep 10 (Thu) brings initial jobless claims, PPI figures, existing home sales, wholesale sales, and several 10-year Treasury auction results. These data points could shift views on rates and risk appetite, and any surprise may move growth names including healthcare services. There is no new earnings event scheduled for the company itself.

## In Short

The stock’s 5.75% weekly gain and 5.66-point outperformance versus the S&P 500 were driven largely by Monday’s gap higher rather than a steady advance through the week. The ratings picture is biased toward buy and overweight, with the consensus target above spot, but the wide $85 to $140 range shows brokers are far from aligned. In the latest session, large-lot money was a net seller while small and medium flows were net buyers, suggesting the rally still lacks broad conviction. The next test will be whether macro data shifts risk appetite and whether the insider disposal disclosure brings more selling pressure.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [HNGE.US](https://longbridge.com/en/quote/HNGE.US.md)

## Related News & Research

- [Hinge Health (HNGE) Stock Looks Above Fair Value After Its 150% Run](https://longbridge.com/en/news/303454834.md)
- [Hinge Health seeks more acquisitions to support growth: Bloomberg](https://longbridge.com/en/news/301179199.md)
- [Starlink AI Acquisition, Spider Digital Technology enter combination agreement](https://longbridge.com/en/news/303819879.md)
- [Down 33.3% this year, is Netflix the best value stock to buy in November?](https://longbridge.com/en/news/303830035.md)
- [Modera Wealth Management LLC Purchases 7,590 Shares of AbbVie Inc. $ABBV](https://longbridge.com/en/news/303828897.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**